REUTERS: Shares of Celgene Corp dived 8 percent on Thursday after a major shareholder in Bristol-Myers Squibb Co came out against a US$74 billion merger that would be the pharmaceutical world's biggest ever takeover.
In the letter to employees, Bristol-Myers reiterated that the Celgene deal is the best path forward for the company and that it continued to believe strongly in the merits of the deal.Bristol-Myers investors are due to vote on the deal at a special meeting scheduled for April 12. "Even with the combined voting power for both Wellington and Starboard Value, we believe there continues to be a high hurdle for opposition to reach majority," said Andy Hsieh, a William Blair analyst.
대한민국 최근 뉴스, 대한민국 헤드 라인
Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.
출처: ChannelNewsAsia - 🏆 6. / 66 더 많은 것을 읽으십시오 »
출처: ChannelNewsAsia - 🏆 6. / 66 더 많은 것을 읽으십시오 »
출처: ChannelNewsAsia - 🏆 6. / 66 더 많은 것을 읽으십시오 »
출처: ChannelNewsAsia - 🏆 6. / 66 더 많은 것을 읽으십시오 »